Chenchen Yu - Concepedia

Concepedia

Author

Chenchen Yu

Fred Hutch Cancer Center

Also Known As

C C Yu, C. Yu, Chen-Chen Yu, Chenchen Yu, Christine Z Yu, Hanscom, Brett, Mayer, Kenneth, Yu, Chenchen

63

Publications

2.5K

Citations

20

H-Index

43

Concepts

All Affiliations

Fred Hutch Cancer Center National Institute of Allergy and Infectious Diseases National Institutes of Health University of Washington Emory University

CY

About

Chenchen Yu is an author at Fred Hutch Cancer Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.7K
2	Allergy	3	3	373
3	Cell Biology	2	2	345
4	Natural Sciences	1	1	27
5	Public Health	1	1	15

Chenchen Yu

×

27

Publications

2.5K

Citations

20

H-Index

	Year	Citations
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial Peter B. Gilbert, David C. Montefiori, Adrian B. McDermott, Science VaccinationVaccine SafetyVaccine DevelopmentVaccine RecipientsImmunology	2022	1.2K
Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells. David B. Lewis, Chenchen Yu, Johann Meyer, Journal of Clinical Investigation Interferon-gamma ProductionLymphocyte DevelopmentT-regulatory CellImmunologyImmune Regulation	1991	258
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial Peter B. Gilbert, David C. Montefiori, Adrian B. McDermott,	2021	137
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial Linda‐Gail Bekker, Zoe Moodie, Nicole Grunenberg, The Lancet HIV	2018	121
Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial Youyi Fong, Yunda Huang, David Benkeser, Nature Communications	2023	96
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial Youyi Fong, Adrian B. McDermott, David Benkeser, Nature Microbiology VaccinationVaccine DevelopmentImmunologyVaccine EfficacyMedicine	2022	89
Interleukin 4 expressed in situ selectively alters thymocyte development. David B. Lewis, Chenchen Yu, Katherine A. Forbush, The Journal of Experimental Medicine Lymphocyte DevelopmentT-regulatory CellImmunologyImmunologic MechanismTransgenic Mouse Model	1991	87
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines Fatima Laher, Zoe Moodie, Kristen W. Cohen, PLoS Medicine	2020	48
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial David Benkeser, David C. Montefiori, Adrian B. McDermott, Science Translational Medicine	2023	45
Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial Youyi Fong, Xiaoying Shen, Vicki C Ashley, The Journal of Infectious Diseases	2018	43

Page 1